Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: all studies registered under CTRI for COVID-19 infections in the year 2020 and 2021
Exclusion criteria
Exclusion criteria: Studies not related to COVID-19
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Total number of trials/studies registered for COVID-19 2.Phase, (Phase I–IV) 3.Nature (interventional or observational) 4.Source of funding (Pharmaceutical Industry/Government of India/Institute Funded) 5.Status of DCGI approval 6.Status of Ethics committee approval 7.National/International 8.Health type 9.Severity of the condition 10.Randomization type 11.Blinding 12.Primary and secondary end points 13.Sample size 14.Duration Timepoint: At the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Total number of trials/studies registered for COVID-19 2. Phase, (Phase I–IV) 3. Nature (interventional or observational) 4. Source of funding (Pharmaceutical Industry/Government of India/Institute Funded) 5. Status of DCGI approval 6. Status of Ethics committee approval 7. National/International 8. Health type 9. Severity of the condition 10. Randomization type 11. Blinding 12. Primary and secondary end points 13. Sample size 14. Duration Timepoint: At the end of the study | — |
Countries
India
Contacts
Public ContactVijaya Laxman Chaudhari
GSMC and KEM Hospital
Outcome results
None listed